Rafferty Asset Management
LENZ icon

Rafferty Asset Management’s LENZ Therapeutics LENZ Stock Holding History

Rafferty Asset Management’s Portfolio LENZ Stock Details LENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-17,716
Closed -$511K – 1154
2024
Q4 		$511K Buy
+17,716
New +$540K ﹤0.01% 908

Other funds holding LENZ

RA Capital Management
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Alpha Wave Global
Alpha Wave Global New York $6.24B AUM 59.73% 1-Year Est. Return
Paradigm Biocapital Advisors
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
7IH
72 Investment Holdings Stamford, Connecticut $50M AUM 647.58% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $143M AUM 102.52% 1-Year Est. Return
RTW Investments
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

Rafferty Asset Management's LENZ Position: Q1 2025 in Review

Rafferty Asset Management sold out of LENZ Therapeutics (LENZ) in Q1 2025, closing a stake of 17,716 shares — an estimated $511K sold.

Rafferty Asset Management first reported a position in LENZ in Q4 2024 and held it in 1 quarter. The position peaked at $511K in Q4 2024. 105 funds tracked by Wall St. Rank hold LENZ as of Q1 2025.

  • Rafferty Asset Management reported no remaining LENZ Therapeutics position as of Q1 2025 after selling out during the quarter.
  • Rafferty Asset Management sold 17,716 LENZ Therapeutics shares in Q1 2025, an estimated $511K.
  • Rafferty Asset Management first reported a position in LENZ Therapeutics in Q4 2024 and held it in 1 quarter.
  • Rafferty Asset Management's LENZ Therapeutics position peaked at $511K in Q4 2024.
  • 105 funds tracked by Wall St. Rank held LENZ Therapeutics as of Q1 2025.

Based on Rafferty Asset Management's 13F filing for Q1 2025, filed 14 May 2025.